Description: Lexington Biosciences, Inc. develops and commercializes non-invasive diagnostic products for cardiovascular health for home and clinical use. It develops HeartSentry, a device for the personalized measurement and monitoring of vascular health to identify cardiovascular disease at its earliest stages. The company is headquartered in Vancouver, Canada.
Home Page: www.lexingtonbiosciences.com
1055 West Hastings Street
Vancouver,
BC
V6E 2E9
Canada
Phone:
800 320 2640
Officers
| Name | Title |
|---|---|
| Mr. Nicholas John Furber CPA | Chief Financial Officer |
| Mr. Donald Arthur McInnes BA | Chief Exec. Officer |
| Dr. Jonathan S. Maltz | Chief Scientific Advisor |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 15.8284 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |